Replies to post #41080 on Rennova Health Inc (RNVA)

[Bidsmaker1]

I highly doubt the authenticity of the vote results since the MMs churned the total A/S almost 4X (possibly higher since I am using older numbers).

The published voting results are very strange (to me). I just don't see any way they could have arrived at those numbers.

So what is the likely outcome at this point?

Upcoming 10Q and the next quarter 10Q should be significantly better since the recent audited 10K had almost 30 million in derivative liability and interest that I believe will be mitigated with this AS increase which helps the bottom line significantly.

The June 1st "hard date" means the company takes over operations 100% on that date. Since revenues from a historic standpoint are proven, the labs owned by RNVA should result in increased revenue or a decrease in costs or both since lab commissions are typically a large cost factor. Of course a lot depends on the spinoff(s) but I think the Hospitals will need the revenue/costs offsets to increase bottom line profitability for the hospitals.

PR should be coming out soon, one for the Jamestown hospital and should see a 10Q very soon.

Now that the revenue and assets of the company have/are significantly increasing, along with the ability of the company to utilize the increased AS for current and future capitalization we could see pricing adjust upwards and start looking more towards future P/E as a basis of pricing. The "unknown" although not really "unknown" will be what Sabby does. If they think the company is likely to refinance the debt under its current obligations they may decide to minimize conversion.

Depends on their game plan but overall I think longs and those who buy on dips and hold will do well.